Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

MLYS

Mineralys Therapeutics (MLYS)

Mineralys Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MLYS
DateTimeSourceHeadlineSymbolCompany
18/06/202406:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MLYSMineralys Therapeutics Inc
18/06/202406:31Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MLYSMineralys Therapeutics Inc
14/06/202422:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
14/06/202422:00GlobeNewswire Inc.Mineralys Therapeutics Appoints Biopharmaceutical Executive Alexander M. Gold, M.D. to its Board of DirectorsNASDAQ:MLYSMineralys Therapeutics Inc
11/06/202406:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
01/06/202406:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
24/05/202406:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MLYSMineralys Therapeutics Inc
23/05/202406:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
09/05/202421:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MLYSMineralys Therapeutics Inc
09/05/202421:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
09/05/202421:00GlobeNewswire Inc.Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:MLYSMineralys Therapeutics Inc
06/05/202422:00GlobeNewswire Inc.Mineralys Therapeutics to Participate in the Bank of America Securities Health Care ConferenceNASDAQ:MLYSMineralys Therapeutics Inc
02/05/202422:00GlobeNewswire Inc.Mineralys Therapeutics to Announce First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 9, 2024NASDAQ:MLYSMineralys Therapeutics Inc
21/03/202422:00GlobeNewswire Inc.Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:MLYSMineralys Therapeutics Inc
14/03/202407:05GlobeNewswire Inc.Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on Thursday, March 21, 2024NASDAQ:MLYSMineralys Therapeutics Inc
16/02/202408:20Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MLYSMineralys Therapeutics Inc
09/02/202408:41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
09/02/202400:00GlobeNewswire Inc.Mineralys Therapeutics Announces $120 Million Private Placement FinancingNASDAQ:MLYSMineralys Therapeutics Inc
30/01/202408:05GlobeNewswire Inc.Mineralys Therapeutics to Participate in the Guggenheim Securities 6th Annual Biotechnology ConferenceNASDAQ:MLYSMineralys Therapeutics Inc
05/01/202408:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
05/01/202408:05GlobeNewswire Inc.Mineralys Therapeutics Appoints Minji Kim, Ph.D. as Chief Business OfficerNASDAQ:MLYSMineralys Therapeutics Inc
23/12/202301:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
22/12/202308:05GlobeNewswire Inc.Mineralys Therapeutics Announces First Subject Dosed in Launch-HTN, the Second Pivotal Trial of Lorundrostat for the Treatment of HypertensionNASDAQ:MLYSMineralys Therapeutics Inc
14/11/202300:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
12/11/202303:30GlobeNewswire Inc.Mineralys Therapeutics Further Defines Endotype-Specific, Targeted Approach to Treatment of Uncontrolled or Resistant Hypertension with Lorundrostat Data at AHA Scientific Sessions 2023NASDAQ:MLYSMineralys Therapeutics Inc
10/11/202308:05GlobeNewswire Inc.Mineralys Therapeutics to Participate in Three Upcoming ConferencesNASDAQ:MLYSMineralys Therapeutics Inc
08/11/202309:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MLYSMineralys Therapeutics Inc
08/11/202308:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
08/11/202308:05GlobeNewswire Inc.Mineralys Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:MLYSMineralys Therapeutics Inc
03/11/202301:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:MLYS